Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lexaria Bioscience Corp LEXX

Alternate Symbol(s):  LEXXW

Healthcare
Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company is engaged in pursuing the enhancement of the bioavailability of a diverse and a range of active pharmaceutical ingredients (API) using DehydraTECH, its patented proprietary drug delivery technology. The Company’s patented drug delivery technology, DehydraTECH, is designed to improve the way active molecules enter the bloodstream upon oral ingestion. DehydraTECH has also demonstrated enhanced delivery of certain active molecules into brain tissue. The Company has also developed DehydraTECH formulations for other applications demonstrating bio-absorption when administered intraorally and topically. It operates through two segments: Intellectual Property and Products. It also operates a licensed in-house research laboratory and holds an intellectual property portfolio with 35 patents granted and many patents pending worldwide. Its subsidiaries include Lexaria CanPharm ULC, and Lexaria CanPharm Holdings Corp.


NDAQ:LEXX - Post by User

Lexaria Bioscience Corp > REMEMBER when AGpicks (eg pumper) liked lexx?
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(33)
•••
Comment by WakeUPPon Jun 06, 2022 2:36pm
77 Views
Post# 34734851

RE:RE:RE:REMEMBER when AGpicks (eg pumper) liked lexx?

RE:RE:RE:REMEMBER when AGpicks (eg pumper) liked lexx?hey ranman do you not know who i am yet?

Do you remember totally hip software?  I made the news in stockwatch several times, before the CEO was fired, and the stock failed.    too bad you cant go back to see what I said there, or know wha tthe CEO TRIED to do to me

the stockwatch reporter knew me as I outed the KRY scammers for what was going on

the chief knew me VERY WELL (on stockhouse lol) as I outed the many scams he pumped, ESPECIALLY the interent radio one

ME, outing scams for over 20 YEARS

oh, who was I on SI...

HERE IS THE TIP:  READ, READ, READ the financials, NOT stock promo.  MOST are going to zero!!!  
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities